Literature DB >> 1152344

[Cardiac effects and glycoside concentrations in serum and urine after oral administration of beta-methy-digoxin to healthy individuals (author's transl)].

R Haasis, D Larbig, K O Klenk.   

Abstract

Six healthy individuals were digitalized orally with beta-methyl-digoxin. The serum glycoside concentration, determined radioimmunologically at the end of the digitalization period was 1.2 +/- 0.22 ng/ml. At this period of time renal excretion attained 55.9% of the daily administered oral dose. The calculated renal clearance of beta-methyl-digoxin was 63 +/- 8.1 ml/min e. g. 57.5 +/- 8.3 ml/min/1.73 m2. After discontinuation of the glycoside the serum half life was 54 h. During the digitalization period the cardiac glycoside effects could be measured by ECG changes, especially a shortening of the QT interval as well as a shortening of the left ventricular ejection time and the pre ejection period, corrected for the heart rate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1152344     DOI: 10.1007/bf01468758

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  13 in total

1.  STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE.

Authors:  J E DOHERTY; W H PERKINS; M C WILSON
Journal:  Am J Med       Date:  1964-10       Impact factor: 4.965

2.  THE EFFECT OF DESLANOSIDE ON THE DURATION OF THE PHASES OF VENTRICULAR SYSTOLE IN MAN.

Authors:  A M WEISSLER; A R KAMEN; R S BORNSTEIN; C D SCHOENFELD; S COHEN
Journal:  Am J Cardiol       Date:  1965-02       Impact factor: 2.778

3.  [Plasma levels of cardiac glycosides and the electrocardiogram during moderately rapid and slow digitalization with beta-methyl-digoxin in normal volunteers (author's transl)].

Authors:  G G Belz; G Rudofsky; G Belz
Journal:  Dtsch Med Wochenschr       Date:  1974-02       Impact factor: 0.628

4.  [Comparative studies on renal and biliary excretion of digoxin and beta-methyldigoxin in man].

Authors:  E Köthe; P Kramer; F Scheler
Journal:  Verh Dtsch Ges Inn Med       Date:  1973

5.  [Metabolism and pharmacokinetics of lanatosides in man].

Authors:  N Rietbrock; U Abshagen
Journal:  Dtsch Med Wochenschr       Date:  1973-01-19       Impact factor: 0.628

6.  [Determination of serum-digoxin concentrations by radioimmunoassay].

Authors:  D Larbig; K Kochsiek
Journal:  Klin Wochenschr       Date:  1971-09-15

7.  [Comulative behavior of various cardiac glycosides in anuria].

Authors:  P Kramer; J Horenkamp; B Willms; F Scheler
Journal:  Dtsch Med Wochenschr       Date:  1970-02-27       Impact factor: 0.628

8.  Systolic time intervals in cardiac disease. I.

Authors:  A M Weissler; C L Garrard
Journal:  Mod Concepts Cardiovasc Dis       Date:  1971-01

9.  [Clinical aspects of the radioimmunochemical determination of serum-digoxin concentration].

Authors:  D Larbig; K Kochsiek; C Schrader
Journal:  Dtsch Med Wochenschr       Date:  1972-02-04       Impact factor: 0.628

10.  Relationship of the excretion of tritiated digoxin to renal function.

Authors:  P M Bloom; W B Nelp; S H Tuell
Journal:  Am J Med Sci       Date:  1966-02       Impact factor: 2.378

View more
  5 in total

1.  Prediction of digoxin dose requirements.

Authors:  S M Dobbs; G E Mawer
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 2.  Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Authors:  P Kramer
Journal:  Klin Wochenschr       Date:  1977-01-01

3.  Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.

Authors:  D Boerner; A Olcay; W Schaumann; W Weiss
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

4.  [Determination of glycoside concentrations in human tissue by means of radioimmunoassay (author's transl)].

Authors:  R Haasis; D Larbig; R Stunkat; H Bader; H Seboldt
Journal:  Klin Wochenschr       Date:  1977-01-01

5.  Serum glycoside concentrations after single or repeated intravenous doses of beta-methyl-digoxin and digoxin.

Authors:  J Marinow; A Olcay; W Schaumann; W Weiss
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.